LIVE STREAM SESSION This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…
SOCIETY: AGA In this session, several clinically relevant presentations will put the attendee at the cutting edge of research and clinical care, with regard to stem cells for perinal fistulas, biologic de-escalation, subcutaneous biologics, and use of small molecules in microscopic colitis
SOCIETY: AGA Progress in understanding how the stromal cells in the intestine take part in forming the villus crypt axis. Also how abnormalilties in the niche lead to disease…
SOCIETY: AGA This session is the second session of the ever-popular and clinically impactful clinical trials sessions in IBD. Insights into novel agents including obefazimod, VTX002. MH002, risankizumab, and mirikizumab will be presented…
SOCIETY: AGA Natural products obtained from diet or microbial derived metabolites are increasingly gaining attention for their potential therapeutic potential in gastro-intestinal disorders…
SOCIETY: AGA This symposium focuses on frustrating scenarios where histopathologic examination of inflammatory gastrointestinal tract biopsies shows findings that do not match a patient's clinical scenario or provide a challenging differential diagnosis…
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…
SOCIETY: AGA Small molecules are a new exicting therapeutic class in IBD that may have potential safety signals which have not been well described in the real world…
SOCIETY: AGA Clinical guidelines increasingly rely on technical reviews of evidence and these in turn are becoming increasingly complex in methods. This offers great promise to truly achieve evidence based clinical guidelines…
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
SOCIETY: AGA This session will provide an insight into the critical, but less commonly studied cells potentially implicated in the pathogenesis of IBD…